Hospital Acquired Infection Control Market Size, Share & Trends Analysis Report By Type (Equipment, Services, Consumables), By End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers), By Region, And Segment Forecasts, 2021 - 2028

Hospital Acquired Infection Control Market Growth Growth & Trends Trends

The global hospital acquired infection control market size is anticipated to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 4.9% from 2021 to 2028. The key factors driving the market growth include the rising incidence of Hospital Acquired Infections (HAIs), supportive government initiatives, and the COVID-19 pandemic. The COVID-19 pandemic has emerged as a major catalyst for the market as it led to increased awareness and concern over HAIs. The demand for infection control equipment and consumables also stemmed from the need to stop the spread of COVID-19.

Governments and regulatory bodies prescribed several policies and guidelines to prevent cross-contamination and safeguard public health. To prevent nosocomial infections in healthcare facilities, infection control standards were implemented such as triage strategy and provision and proper distribution of equipment, in addition to standard precautions such as hand washing and use of personal protective equipment. In particular, the pandemic resulted in a surge in demand for consumables such as PPE, masks, and disinfectants.

The CDC, of the U.S. Department of Health and Human Services, provides an extensive library of guidelines on basic infection prevention and control, antibiotic resistance, device-associated infections, procedure-associated infections, and disease / organism-specific to promote the control of HAIs. In the wake of the pandemic, the CDC added COVID-19 infection control guidelines to its digital library.

Growing initiatives by market players also contribute to the growth of the market. These initiatives include strategic partnerships, mergers and acquisitions, and product development. In February 2021, for instance, Getinge expanded its partnership with XPO Logistics under which the latter will provide warehousing and transport services from the Netherlands to the EMEA region for the company’s infection control business unit. In December 2020, Xenex launched LightStrike 6 as part of its patented lineup of pathogen-eliminating robots. The robots produce high-intensity broad-spectrum UV light and can also deactivate the COVID-19 virus in 2 minutes.

Hospital Acquired Infection Control Market Report Highlights

  • The consumables segment dominated the market and accounted for the largest revenue share of 47.0% in 2020. This was owing to the high usage of consumables in hospitals and ambulatory care centers. The COVID-19 pandemic further contributed to the segment share due to the increased need for disposable, safe, and effective solutions to curb the spread of the virus. These included products such as N95 masks, PPE, and gloves
  • The hospitals and Intensive Care Units (ICUs) segment held the largest revenue share of 46.0% in 2020 due to the high prevalence of healthcare-associated infections (HCAIs) in these facilities. According to CDC estimates, about 1 out of 31 hospital patients suffer from at least one HAI on any given day
  • In Asia Pacific, the market is anticipated to witness lucrative growth in coming years owing to increasing supportive government initiatives to promote HAIs control products in the region
  • Strategic initiatives by market players are mergers and acquisitions, collaboration, geographic expansions, and new product development. For example, in November 2020, Getinge acquired a manufacturer of decontamination products-Quadralene. The company was merged into Getinge’s Infection Control portfolio to expand its offerings in the business area of Surgical Workflows
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Report Objectives
Chapter 2 Executive Summary
2.1 Hospital Acquired Infection Control Market Summary
Chapter 3 Hospital Acquired Infection Control Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2020
3.3 Hospital Acquired Infection Control Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3. Market Challenge Analysis
3.3.4. Market Opportunity Analysis
3.4 Hospital Acquired Infection Control Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Hospital Acquired Infection Control Industry Analysis - PEST (Political & Legal, Economic, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Technology Landscape
3.6. Regulatory Landscape
3.7. Prevalence of Hospital Acquired Infections
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Prevalence Analysis
4.2. Regulatory requirements/changes due to COVID-19
4.3. Strategies implemented by companies
Chapter 5 Hospital Acquired Infection Control Market: Segment Analysis, By Type, 2016 - 2028 (USD Million)
5.1 Type Market Share Analysis, 2020 & 2028
5.2 Hospital Acquired Infection Control market, by Type, 2016 to 2028
5.3 Equipment
5.3.1 Equipment market, 2016 - 2028 (USD Million)
5.3.2 Sterilization Equipment
5.3.2.1 Sterilization Equipment market, 2016 - 2028 (USD Million)
5.3.2.2 Heat Sterilization Equipment
5.3.2.2.1 Heat Sterilization Equipment market, 2016 - 2028 (USD Million)
5.3.2.2.2 Moist Heat Sterilization
5.3.2.2.2.1 Moist Heat Sterilization market, 2016 - 2028 (USD Million)
5.3.2.2.3 Dry Heat Sterilization
5.3.2.2.3.1 Dry Heat Sterilization market, 2016 - 2028 (USD Million)
5.3.2.3 Low Temperature Sterilization
5.3.2.3.1 Low Temperature Sterilization market, 2016 - 2028 (USD Million)
5.3.2.4 Radiation Sterilization
5.3.2.4.1 Radiation Sterilization market, 2016 - 2028 (USD Million)
5.3.2.5 Others
5.3.2.5.1 Others market, 2016 - 2028 (USD Million)
5.3.3 Disinfection Equipment
5.3.3.1 Disinfection Equipment market, 2016 - 2028 (USD Million)
5.4 Services
5.4.1 Services market, 2016 - 2028 (USD Million)
5.5 Consumables
5.5.1 Consumables market, 2016 - 2028 (USD Million)
5.5.2. Disinfectants
5.5.2.1. Disinfectants market, 2016 - 2028 (USD Million)
5.5.3. Sterilization consumables
5.5.3.1. Sterilization consumables market, 2016 - 2028 (USD Million)
5.5.4. Others (waste disposal, PPE)
5.5.4.1. Others (waste disposal, PPE) market, 2016 - 2028 (USD Million)
Chapter 6 Hospital Acquired Infection Control Market: Segment Analysis, By End User, 2016 - 2028 (USD Million)
6.1 End-user Market Share Analysis, 2020 & 2028
6.2 Hospital Acquired Infection Control market, by End User, 2016 to 2028
6.3 Hospitals and Intensive Care Units (ICUs)
6.3.1 Hospitals and Intensive Care Units (ICUs) market, 2016 - 2028 (USD Million)
6.4 Ambulatory Surgical and Diagnostic Centers
6.4.1 Ambulatory Surgical and Diagnostic Centers market, 2016 - 2028 (USD Million)
6.5 Others (Nursing Homes and Maternity Centers)
6.5.1 Others (Nursing Homes and Maternity Centers) market, 2016 - 2028 (USD Million)
Chapter 7 Hospital Acquired Infection Control Market: Regional Market Analysis 2016 - 2028 (USD Million)
7.1 Regional Market Share Analysis, 2020 & 2028
7.2 Regional Market Snapshot
7.3 Market Size, & Forecasts, and Trend Analysis, 2016 to 2028
7.4 North America
7.4.1 North America Hospital Acquired Infection Control Market Share Analysis, By Country, 2020
7.4.2. U.S.
7.4.2.1 U.S. Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.4.3 Canada
7.4.3.1 Canada Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.5 Europe
7.5.1 Europe Hospital Acquired Infection Control Market Share Analysis, By Country, 2020
7.5.2 U.K.
7.5.2.1 U.K. Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.5.3 Germany
7.5.3.1 Germany Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.5.4 France
7.5.4.1 France Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.5.5 Italy
7.5.5.1 Italy Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.5.6 Spain
7.5.6.1 Spain Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.6 Asia Pacific
7.6.1 Asia Pacific Hospital Acquired Infection Control Market Share Analysis, By Country, 2020
7.6.2 Japan
7.6.2.1 Japan Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.6.3 China
7.6.3.1 China Hospital Acquired Infection Control Market, 2016 - 2028 (USD million)
7.6.4 India
7.6.4.1 India Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.6.5 Australia
7.6.5.1 Australia Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.6.6 South Korea
7.6.6.1 South Korea Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.7 Latin America
7.7.1 Latin America Hospital Acquired Infection Control Market Share Analysis, by country, 2020
7.7.2 Brazil
7.7.2.1 Brazil Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.7.3 Mexico
7.7.3.1 Mexico Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.7.4 Argentina
7.7.4.1 Argentina Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.8 MEA
7.8.1 MEA Hospital Acquired Infection Control MARKET SHARE ANALYSIS, BY COUNTRY, 2020
7.8.2 South Africa
7.8.2.1 South Africa Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.8.3 Saudi Arabia
7.8.3.1 Saudi Arabia Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
7.8.4 UAE
7.8.4.1 UAE Hospital Acquired Infection Control Market, 2016 - 2028 (USD Million)
Chapter 8 Hospital Acquired Infection Control Market - Competitive Analysis
8.1 Market Participant Categorization
8.1.1. Company Market Position Analysis
8.1.2. Synergy Analysis: Major Deals & Strategic Alliances
8.1.3. Market Leaders
8.1.4. Innovators
8.2. List of Key Companies
Chapter 9 Hospital Acquired Infection Control Market - Company Profiles
9.1 Olympus Corporation
9.1.1 Company overview
9.1.2 FINANCIAL PERFORMANCE
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 BD
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Getinge AB
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Xenex Disinfection Services Inc.
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 3M
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 STERIS
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 ASP (Advanced Sterilization Products)
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Ecolab
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.9 Belimed AG
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 KCWW (Kimberly-Clark Worldwide, Inc.)
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook